Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2003
12/04/2003WO2002083892A3 Mutants of desoxycytidine kinase having extended enzymatic activity
12/04/2003WO2002081626A3 D-hydantoinase from ochrobactrum anthropi
12/04/2003WO2002081519A9 Ifn-thy fusion protein,dna coding therefore,its preparation and application
12/04/2003WO2002080846A3 Epothilone derivatives and methods for making and using the same
12/04/2003WO2002074986A3 An early pre-symptomatic prion diagnostic blood test for encephalopathies
12/04/2003WO2002070708A3 Glutamate receptor modulatory proteins and nucleic acids encoding them
12/04/2003WO2002066664A3 Method for the production of d-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002057427A3 Mammalian tumor susceptibility gene products and their uses
12/04/2003WO2002036806A9 Expression vectors able to elicit improved immune response and methods of using same
12/04/2003US20030226162 Genetically engineered woody plants with enhanced glucosyltransferase activity; papermaking
12/04/2003US20030226161 Salutaridinol 7-O-acetyltransferase and derivatives thereof
12/04/2003US20030225257 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
12/04/2003US20030225253 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/04/2003US20030225017 Chlamydia antigens and corresponding DNA fragments and uses thereof
12/04/2003US20030225006 Novel spinosyn-producing polyketide synthases
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224521 Using artificial bacterial chromosome and homologous recombination as tools for stable transfer of genetic material into cells; gene replacement; transgenic animal models
12/04/2003US20030224500 Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereof
12/04/2003US20030224499 Comprises nucleotide sequences coding phosphotransferase subunit for fermentation of lysine; animal feeds; medicines; human nutrients
12/04/2003US20030224495 Synthesis performed in enantiomer-pure form with chorismate by cultivation of genetically altered non-pathogenic organism which has aromate embolism and increased activity of isochorismate synthase and isochorismatase
12/04/2003US20030224493 Comprises genetically engineered biooxidation enzyme for conversion of oleic acid into a 18-carbon dicarboxylic acid
12/04/2003US20030224491 Continuous fermentation process
12/04/2003US20030224488 Materials and methods for preparing dimeric growth factors
12/04/2003US20030224484 Plasmid for transferring genetic information into prokaryotic gene sequences/operons using directed homologous recombination
12/04/2003US20030224483 Control of gene expression in eukaryotic cells
12/04/2003US20030224482 Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
12/04/2003US20030224481 In vivo gene transfer
12/04/2003US20030224458 Novel human G-protein coupled receptor, HGPRBMY23, expressed highly in kidney
12/04/2003US20030224454 Human solute carrier family 7, member 11 (hSLC7A11)
12/04/2003US20030224450 Comprises nucleotide sequences coding transient receptor potential channel (TRP) for use in diagnosis and treatment of osteoporosis, nervous system, kidney and cancer disorders
12/04/2003US20030224427 Comprises DNAX interferon-like receptor subunit (DIRS) polypeptide for use in diagnosis and treatment of inflammation and blood disorders
12/04/2003US20030224410 Selecting nucleic acid sequences coding ligand and receptor molecules capable of specific binding to each other for use in epitope mapping; rational drug design
12/04/2003US20030224405 Transcriptional regulator
12/04/2003US20030224401 Proteins for helicobacter diagnosis
12/04/2003US20030224383 Atherosclerotic phenotype determinative genes and methods for using the same
12/04/2003US20030224379 Novel nucleic acids and polypeptides
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224350 Elimination of endogenous porcine retrovirus
12/04/2003US20030224012 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis
12/04/2003US20030224009 An expression vector containing a promoter co-dependently regulatable by cyclic AMP and anaerobiosis, capable of at least one: being chromosomally integrated in bacterial cell, and being maintained extrachromosomally in a bacterial cell
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
12/04/2003US20030223994 Protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223976 Control sequences of the human corin gene
12/04/2003US20030223961 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
12/04/2003CA2771788A1 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
12/04/2003CA2694419A1 Isolated polynucleotides and methods of promoting a morphology in a fungus
12/04/2003CA2492380A1 An exposure device
12/04/2003CA2487243A1 Transformed fungi for production of recombinant proteins
12/04/2003CA2487143A1 Regulation of novel human asparagine-hydroxylases
12/04/2003CA2487021A1 Probiotics and oral tolerance
12/04/2003CA2486618A1 Methods for the in vitro culture of sporozoea sp. and uses thereof
12/04/2003CA2486578A1 Detection of secreted polypeptides
12/04/2003CA2485837A1 Methods and dna constructs for high yield production of polypeptides
12/04/2003CA2485829A1 Methods and constructs for high yield expression of clostripain
12/04/2003CA2485732A1 Generation and selection of protein library in silico
12/04/2003CA2484000A1 Neutralizing human anti-igfr antibody
12/04/2003CA2483201A1 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/03/2003EP1367130A1 Process for the preparation of L-amino acids using coryneform bacteria which contain an attenuated MalE gene
12/03/2003EP1367126A1 Novel vectors for animal cells and utilization thereof
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1367078A2 Method of producing polyhydroxyalkanoate from alkane having residue containing aromatic ring in its molecule
12/03/2003EP1366202A1 A method for the bacterially assisted heap leaching of chalcopyrite
12/03/2003EP1366180A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
12/03/2003EP1366176A2 Synthetic genes and bacterial plasmids devoid of cpg
12/03/2003EP1366175A2 Multifunctional protease inhibitors and their use in treatment of disease
12/03/2003EP1366174A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
12/03/2003EP1366173A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
12/03/2003EP1366166A2 Molecules for diagnostics and therapeutics
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366158A2 Trp8, trp9 and trp10, markers for cancer
12/03/2003EP1366157A2 Compositions and methods for the therapy and diagnosis of lung cancer
12/03/2003EP1366156A2 Osteolevin gene polymorphisms
12/03/2003EP1366155A1 Methods and agents for modifying human angiogenesis
12/03/2003EP1366152A2 G-protein coupled receptors
12/03/2003EP1366146A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366077A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
12/03/2003EP1366073A2 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof
12/03/2003EP1366067A2 Expression technology for proteins containing a hybrid isotype antibody moiety
12/03/2003EP1365802A2 Salmonella promoter for heterologous gene expression
12/03/2003EP1124813B1 Microbial transformation product
12/03/2003EP0765393B1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
12/03/2003EP0724644B1 Dna encoding 1,3-beta-d glucan synthase subunits
12/03/2003CN1460110A Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1459505A Chinese Han nationality people stroma metallopankrin-9 gene reconstitution, expression, purification and its medical application
12/03/2003CN1459439A City sludge biofertilizer
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/03/2003CN1129666C Human tissue inhibitor of metalloproteinase -4
12/03/2003CN1129665C Ammonium resistant engineering bacterium and biologic fertilizer containing it
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656917 Compositions and methods for targeted enzymatic release of cell regulatory compounds
12/02/2003US6656905 Cyclic tetrapeptide compound and use thereof
12/02/2003US6656746 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders
12/02/2003US6656736 Methods for generating hypermutable yeast
12/02/2003US6656721 Of given sequence; media containing microorganism with a mutation which causes auxotrophic growth; excess production of riboflavin